0001367644-19-000016 Sample Contracts

Emergent BioSolutions Inc. Form of Restricted Stock Unit Award Agreement
Restricted Stock Unit Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
EMERGENT BIOSOLUTIONS INC. Form of Director Restricted Stock Unit Agreement
Restricted Stock Unit Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware

This Restricted Stock Unit Agreement is made as of the Agreement Date between Emergent BioSolutions Inc. (the “Company”), a Delaware corporation, and the Participant.

Sample 1Sample 2Sample 3
Non-Qualified Stock Option Award Agreement
Non-Qualified Stock Option Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
Sample 1Sample 2
Form of Restricted Stock Unit Award Agreement – Canadian Participant
Restricted Stock Unit Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
Sample 1Sample 2
Form of Director Nonstatutory Stock Option Agreement
Director Nonstatutory Stock Option Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
Sample 1Sample 2
AMENDMENT NO. 1 TO LICENSE AGREEMENT
License Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations

This Amendment No. 1 to License Agreement (this “Amendment”) is made as of December 13, 2016, by and among Opiant Pharmaceuticals Inc. (formerly known as Lightlake Therapeutics Inc.), a Nevada corporation (“Opiant”), and Adapt Pharma Operations Limited, an Irish limited company (“Adapt”). Opiant and Adapt are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used but not defined herein have the meanings given to them in the License Agreement (as defined below).

Sample 1
Non-Qualified Stock Option Award Agreement – Irish Participant
Non-Qualified Stock Option Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
Sample 1
Form of UK Restricted Stock Unit Award Agreement – UK Participant
Restricted Stock Unit Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
Sample 1
LICENSE AGREEMENT between LIGHTLAKE THERAPEUTICS INC. and ADAPT PHARMA OPERATIONS LIMITED Dated as of December 15, 2014
License Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York

This License Agreement (the “Agreement”) is made and entered into effective as of December 15, 2014 (the “Effective Date”) by and between Lightlake Therapeutics Inc., a Nevada corporation (“Lightlake”), and Adapt Pharma Operations Limited, an Irish limited company (“Adapt”). Lightlake and Adapt are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.

Sample 1
Form of Restricted Stock Unit Award Agreement – Irish Participant
Restricted Stock Unit Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
Sample 1
Non-Qualified Stock Option Award Agreement – Canadian Participant
Non-Qualified Stock Option Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
Sample 1
Non-Qualified UK Stock Option Award Agreement – UK Participant
Non-Qualified Stock Option Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!